| | 1401436-95-0 Basic information More.. |
| Product Name: | 4-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-N-(2-methyl-1-(2-(1-methylpiperidin-4-yl)phenyl)propan-2-yl)-6-morpholino-1,3,5-triazin-2-amine | | Synonyms: | 4-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-N-(2-methyl-1-(2-(1-methylpiperidin-4-yl)phenyl)propan-2-yl)-6-morpholino-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)-1H-1,3-benzodiazol-1-yl]-N-{2-methyl-1-[2-(1-methylpiperidin-4-yl)phenyl]propan-2-yl}-6-(morpholin-4-yl)-1,3,5-triazin-2-amine;1,3,5-Triazin-2-amine, 4-[2-(difluoromethyl)-1H-benzimidazol-1-yl]-N-[1,1-dimethyl-2-[2-(1-methyl-4-piperidinyl)phenyl]ethyl]-6-(4-morpholinyl)-;Zandelisib;PWT-143;EOS-60789;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-(1-methylpiperidin-4-yl)phenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;PWT143,3-kinase,Phosphatidylinositol,Zandelisib,inhibit,ME401,Phosphoinositide 3-kinase,PWT-143,PWT 143,antineoplastic,PI3K,ME-401,ME 401,Inhibitor,p110δ | | CAS: | 1401436-95-0 | | MF: | C31H38F2N8O | | MW: | 576.6832264 | | EINECS: | | | Mol File: | 1401436-95-0.mol |  |
4-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-N-(2-methyl-1-(2-(1-methylpiperidin-4-yl)phenyl)propan-2-yl)-6-morpholino-1,3,5-triazin-2-amine manufacturers
- Zandelisib
-
- US $89.00-317.00 / mg
- 2025-11-10
- CAS:1401436-95-0
- Min. Order:
- Purity: 99.15%
- Supply Ability: 10g
- Zandelisib
-
- US $89.00-317.00 / mg
- 2025-11-10
- CAS:1401436-95-0
- Min. Order:
- Purity: 99.15%
- Supply Ability: 10g
|
|
1401436-95-0
Recommend Suppliers |
|